Immune-related gene expression signature in patients with recurrent/metastatic head and neck cancer treated with immunotherapy.

被引：0
|
作者：
Licitra, Lisa F.
Serafini, Mara Serena
Pistore, Federico
Lenoci, Deborah
Airoldi, Mario
Rocca, Maria Cossu
Strojan, Primoz
Kuhar, Cvetka Grasic
Merlano, Marco C.
Denaro, Nerina
Perri, Francesco
Argiris, Athanassios
Gurizzan, Cristina
Perrone, Federica
Ghi, Maria Grazia
Cassano, Alessandra
Allegrini, Giacomo
De Cecco, Loris
Bossi, Paolo
机构：
[1] Univ Milan, Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] IRCCS Fdn Ist Nazl Tumori, Milan, Italy
[3] Fdn IRCCS Ist Nazl Tumori, Head & Neck Med Oncol Dept, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Dept Appl Res & Technol Dev, Integrated Biol Platform, Milan, Italy
[5] Citt Salute Scienza, Med Oncol Div 2, Turin, Italy
[6] Urogenital & Head & Neck Tumors, Div Med Oncol, Milan, Italy
[7] European Inst Oncol, Milan, Italy
[8] Inst Oncol Ljubljana, Ljubljana, Slovenia
[9] Azienda Osped Santa Croce Carle, Cuneo, Italy
[10] AO S Croce & Carle, Med Oncol, Cuneo, Italy
[11] Fdn Pascale, Naples, Italy
[12] Thomas Jefferson Univ, Dept Med Oncol, Athens, Greece
[13] Univ Brescia, Dept Med & Surg Specialties, Med Oncol Unit, Radiol Sci Publ Hlth, Brescia, Italy
[14] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy
[15] Osped Angelo, Mestre Venezia, Mestre Venezia, Italy
[16] UOC, Fdn Policlin Univ Gemelli, IRCCS, Oncol Med, Rome, Italy
[17] Azienda USL Toscana Nord Ovest, Livorno, Italy
[18] Fdn IRCCS Ist Nazl Tumori, Dept Exp Oncol & Mol Med, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6051
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Suppressive immune profile in combined positive score positive head and neck cancer patients treated with immunotherapy.
    Botticelli, Andrea
    Cirillo, Alessio
    Cerbelli, Bruna
    Roberto, Michela
    Carletti, Raffaella
    Chiavassa, Antonella
    Gambaro, Francesco
    Valentini, Valentino
    De Vincentiis, Marco
    De Felice, Francesca
    della Rocca, Carlo
    Mezi, Silvia
    Romeo, Umberto
    Tomao, Silverio
    Corsi, Alessandro
    D'Amati, Giulia
    Messineo, Daniela
    Polimeni, Antonella
    Marchetti, Paolo
    di Gioia, Cira
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18014 - E18014
  • [2] Immunotherapy for recurrent/metastatic head and neck cancer
    Alfieri, Salvatore
    Cavalieri, Stefano
    Licitra, Lisa
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2018, 26 (02): : 152 - 156
  • [3] Radiomic features in recurrent/metastatic platinum refractory head and neck squamous cell carcinoma treated with immunotherapy.
    Anile, Giuseppe
    Bettinelli, Andrea
    Paiusco, Marta
    De Conti, Giorgio
    Gottardi, Chiara
    Conte, Pierfranco
    Ghi, Maria Grazia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Gastrostomy, tracheostomy, opioid, and health care utilization among patients with recurrent/metastatic head and neck cancer receiving immunotherapy.
    Uy, Natalie F.
    Ng, Kevin
    Voutsinas, Jenna M.
    Wu, Vicky
    Futran, Neal D.
    Houlton, Jeffrey
    Barber, Brittany
    Laramore, George E.
    Parvathaneni, Upendra
    Liao, Jay Justin
    Rodriguez, Cristina P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 296 - 296
  • [5] Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
    She, Yangyang
    Kong, Xiangbo
    Ge, Yaping
    Yin, Ping
    Liu, Zhiyong
    Chen, Jieyu
    Gao, Feng
    Fang, Silian
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [6] Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma
    Yangyang She
    Xiangbo Kong
    Yaping Ge
    Ping Yin
    Zhiyong Liu
    Jieyu Chen
    Feng Gao
    Silian Fang
    Cancer Cell International, 20
  • [7] Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse events
    Yasumatsu, Ryuji
    Matsuo, Mioko
    Wakasaki, Takahiro
    Masuda, Muneyuki
    Takeuchi, Toranoshin
    Manako, Tomomi
    Jiromaru, Rina
    Uchi, Ryutaro
    Hashimoto, Kazuki
    Nakagawa, Takashi
    ACTA OTO-LARYNGOLOGICA, 2020, 140 (12) : 1043 - 1048
  • [8] Immune-related adverse events in advanced NSCLC treated with immunotherapy alone or concurrent chemotherapy and immunotherapy.
    Melson, John
    Reed, Daniel
    Horton, Bethany J.
    Moore, Margaret
    Brown, Jacqueline Theresa
    Gentzler, Ryan D.
    Hall, Richard Delmar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [9] Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
    Albarran-Artahona, Victor
    Laguna, Juan-Carlos
    Gorria, Teresa
    Torres-Jimenez, Javier
    Pascal, Mariona
    Mezquita, Laura
    DIAGNOSTICS, 2022, 12 (09)
  • [10] A Retrospective Analysis of a Cohort of Patients Treated With Immune Checkpoint Blockade in Recurrent/Metastatic Head and Neck Cancer
    Bila, Michel
    Van Dessel, Jeroen
    Smeets, Maximiliaan
    Vander Poorten, Vincent
    Nuyts, Sandra
    Meulemans, Jeroen
    Clement, Paul M.
    FRONTIERS IN ONCOLOGY, 2022, 12
12345